Category: Covid-19 Vaccine

Page 206«..1020..205206207208..220230..»

COVID-19 Daily Update 10-14-2022 – West Virginia Department of Health and Human Resources

October 15, 2022

The West Virginia Department of Health and Human Resources (DHHR) reports as of October 14, 2022, there are currently 903 active COVID-19 cases statewide. There have been 13 deaths reported since the last report, with a total of 7,470 deaths attributed to COVID-19.

DHHR has confirmed the deaths of a 78-year old female from Raleigh County, an 80-year old female from Cabell County, a 64-year old male from Taylor County, a 67-year old female from Wyoming County, a 91-year old male from Brooke County, a 72-year old female from Mercer County, a 45-year old female from Mercer County, a 97-year old female from Raleigh County, a 96-year old female from Jefferson County, a 70-year old female from Kanawha County, a 73-year old female from Taylor County, a 72-year old female from Monongalia County, and a 99-year old female from Raleigh County.

"The more people who choose to get vaccinated and boosted, the safer everyone can be," said Bill J. Crouch, DHHR Cabinet Secretary. "COVID vaccines and boosters are widely available, free and easy to schedule."

CURRENT ACTIVE CASES PER COUNTY: Barbour (6), Berkeley (76), Boone (7), Braxton (9), Brooke (23), Cabell (24), Calhoun (3), Clay (2), Doddridge (2), Fayette (13), Gilmer (5), Grant (5), Greenbrier (19), Hampshire (10), Hancock (13), Hardy (9), Harrison (42), Jackson (13), Jefferson (31), Kanawha (77), Lewis (11), Lincoln (10), Logan (39), Marion (31), Marshall (10), Mason (12), McDowell (9), Mercer (38), Mineral (19), Mingo (19), Monongalia (32), Monroe (9), Morgan (16), Nicholas (8), Ohio (16), Pendleton (1), Pleasants (4), Pocahontas (9), Preston (20), Putnam (16), Raleigh (40), Randolph (5), Ritchie (4), Roane (12), Summers (8), Taylor (7), Tucker (0), Tyler (5), Upshur (9), Wayne (13), Webster (6), Wetzel (2), Wirt (1), Wood (46), Wyoming (27). To find the cumulative cases per county, please visit http://www.coronavirus.wv.gov and look on the Cumulative Summary tab which is sortable by county.

West Virginians ages 6 months and older are eligible for COVID-19 vaccination. All individuals ages 6 months and older should receive a primary series of vaccination, the initial set of shots that teaches the body to recognize and fight the virus that causes COVID-19. At this time, one Omicron booster shot (bivalent) is recommended for everyone ages 5 years and older who completed the primary series, and their most recent COVID-19 shot was at least 2 months ago.

Visit the WV COVID-19 Vaccination Due Date Calculator, a free, online tool that helps individuals figure out when they may be due for a COVID-19 shot, making it easier to stay up-to-date on COVID-19 vaccination. To learn more about COVID-19 vaccines, or to find a vaccine, visit vaccines.gov, vaccinate.wv.gov, or call 1-833-734-0965. Please visit the COVID-19 testing locations page to locate COVID-19 testing near you.

Read more from the original source:

COVID-19 Daily Update 10-14-2022 - West Virginia Department of Health and Human Resources

Five things you need to know about COVID-19 vaccines and your period – Gavi, the Vaccine Alliance

October 15, 2022

Women have been reporting anecdotally for months now that their periods were being affected by COVID-19 vaccines, and a major new global study reporting on a quarter of a million menstrual cycles, recorded by almost 20.000 individuals, has confirmed that the vaccine can alter menstrual cycles slightly but crucially, the effect is temporary.

Although such fluctuations may not have a lasting effect on womens health, changes to a biological process linked to fertility can cause concern and should be addressed appropriately so that it doesnt fuel vaccine hesitancy, say scientists.

A team led by Alison Edelman at Oregon Health and Science University in Portland, USA, undertook a global retrospective study using data collected, with consent, through a period tracking app. They found that vaccinated people saw their cycles become shorter or longer, but with a change of less than a day on average, whereas people who had not been vaccinated saw no change. Women who received both vaccine doses in a single menstrual period saw their cycle increase by 3.91 days.

This study builds on a previous smaller US study that found similar results. In this global study, they analysed data from 19,622 individuals aged 18 to 45 years with cycle lengths of 24 to 38 days; 14,936 were vaccinated and 4,686 were unvaccinated. The participants were at least three cycles after pregnancy or after use of hormonal contraception and not menopausal. Thus, the researchers report on more than a quarter of a million menstrual cycles recorded by almost 20,000 individuals.

A change in cycle length of up to eight days is considered within normal variation. However, more than 1,300 people had a clinically significant change in cycle length of eight days or more, and this was significantly higher in the vaccinated group (6.2%) compared with 5.0% in the unvaccinated. It is still not clear why some saw such large variations in cycle length and what the mechanisms driving this are, say the researchers.

Scientists have been trying to calm fears over fertility being affected by COVID-19 vaccination since anecdotal reports over altered periods surfaced. That vaccines could affect fertility is a common myth Dr Soumya Swaminathan, Chief Scientist at the World Health Organization (WHO) has said previously. Earlier this year, a study of 2,000 couples trying to conceive without fertility treatment showed that COVID-19 vaccination did not affect peoples chances of getting pregnant.

Dr Amelia Wesselink and her team at Boston University School of Public Health analysed data from a pregnancy study that follows US and Canadian women aged 21 to 45 years trying to conceive. The study published in the American Journal of Epidemiology found that either partners vaccination status did not alter their chance of conceiving.

However, while no link between vaccination and fertility has been discovered, there is a link with the disease the vaccine fights. The team found that conception during a given menstrual cycle was less likely if the male partner had tested positive for COVID-19 up to 60 days earlier. Indeed, COVID-19 can be a major risk to both the mother and baby. Pregnant women with moderate to severe COVID-19 may face a greater risk of death or serious illness from complications. Their babies may also be at greater risk of preterm birth, stillbirth or newborn death, which vaccination against COVID-19 can prevent.

The slight change in the length of the menstrual cycle did not affect the length of the period. For most people, the change in cycle length resolved by the next period.

Participants received one of nine different vaccines: Pfizer-BioNTech, Moderna, Johnson & Johnson, AstraZeneca, Covishield, Sputnik, Covaxin, Sinopharm and Sinovac. The changes in menstrual cycle length did not differ between vaccines.

Continued here:

Five things you need to know about COVID-19 vaccines and your period - Gavi, the Vaccine Alliance

Denver COVID-19 Status Update: Oct. 14, 2022 – City and County of Denver

October 15, 2022

Published on October 14, 2022

The City and County of Denver provided the following COVID-19 status update.

The Time is Now for Seasonal Flu Shots

Flu cases are already rising in parts of the U.S., according to the Centers for Disease Control and Prevention (CDC). Pediatricians are also seeing a growing number of children sick with respiratory syncytial virus, or RSV, and enteroviruses.

The Denver Department of Public Health & Environment (DDPHE) anticipates more flu activity this winter than the previous two years. DDPHE recommends everyone get a flu shot as getting a flu vaccine is an essential part of protecting your health and your familys health every year.

Flu shots are readily available. Medicare, Medicaid and most private health insurers cover the full cost of a flu vaccine. Some pharmacies, like CVS and Walgreens offer free flu shots.

DDPHE continues to urge everyone to be mindful and take precautions when going about their fall routines. If you feel sick, stay home and get tested. More information and resources are available at denvergov.org/covid19.

Feds Greenlight Updated Omicron Booster for Kids

The federal government has cleared the way for elementary school-aged children to get the updated Omicron booster shot. Two versions are available; one made by Pfizer for 5- to 11-year-olds, and a version from Moderna for 611-year-olds, and one for 12-17-year-olds. The doses are modified to target todays most common and contagious Omicron strain. DDPHE encourages everyone to get the extra protection ahead of holiday gatherings.

DDPHE recognizes many people may be tired of repeated calls to get boosted against COVID-19, but experts say the updated shots have an advantage: They contain half the recipe that targeted the original coronavirus strain and half protection against the dominant BA.4 and BA.5 Omicron versions. These combination or bivalent boosters are designed to broaden immune defenses, so people are better protected against serious illness whether they encounter an Omicron relative in the coming months -- or a different mutation thats more like the original virus.All COVID-19 vaccines and boosters are safe and free. Additional resources about COVID-19 vaccines and boosters can be found on the DDPHE COVID-19 webpage.

Denver County Current CDC Level: Low/Green

Denver County Current Status

*Numbers represent data as of Thursday, Oct., 13, 2022 and are subject to change.

Denver residents 6 months and older initiating vaccination 1st dose received: 85.3%

Denver residents 6 months and older completing vaccinationFully vaccinated: 77.9%

Denver residents 5 and older receiving booster dose- after initial vaccine series: 50.4%

Denver one-week cumulative incidence rate (7-day average of cases per 100,000 population)

As of 10/12/22: 58.7 per 100,000

Denver one-week average positivity rate*

As of 10/12/22: 4.9%

Hospitalizations

Persons hospitalized with COVID-19 in Denver County: 21 (as of 10/12/22)

Case Summary

Cumulative Denver positive cases: 212,749 (as of 10/13/22)

Cumulative Denver deaths from COVID-19: 1,466 (as of 10/13/22)

Follow this link:

Denver COVID-19 Status Update: Oct. 14, 2022 - City and County of Denver

Flush with Covid cash, BioNTech founders have outsized ambitions – STAT

October 15, 2022

BOSTON BioNTech CEO Uur ahin had been in marathon meetings since he arrived in this city three days earlier, but if his energy had flagged it didnt show. The clock had not even struck 8 a.m., and there was ahin, in front of a table at the Four Seasons strewn with continental breakfast, deep in discussion with HIV expert Bruce Walker of the Ragon Institute.

Before Walker left, ahin asked a reporter, newly arrived, to snap a photo of them to commemorate the moment.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

Visit link:

Flush with Covid cash, BioNTech founders have outsized ambitions - STAT

Concerns about California winter COVID wave increase – Los Angeles Times

October 15, 2022

While coronavirus cases in California remain fairly under control, a new rise in Europe is fueling fresh concerns about a potential winter wave here.

Britain, France, Germany and Italy have all reported increasing coronavirus cases since mid-September, according to data presented by Los Angeles County Public Health Director Barbara Ferrer.

Throughout the pandemic, trends and cases in Europe have served as a predictor for trending cases in the United States. This was true at the beginning of the pandemic in March of 2020, and also before each of our subsequent surges. And we should be prepared for it to possibly be true again, Ferrer said.

Ferrer said there is no need for immediate concern about a number of new Omicron subvariants that health officials are closely tracking nationwide. Still, some experts are predicting the subvariants have a greater evolutionary advantage than their predecessors, meaning that theyre more contagious; they can crowd out other circulating COVID viruses; and they can break through protection, such as prior infections and vaccinations.

The U.S. Centers for Disease Control and Prevention on Friday estimated that the share of weekly coronavirus cases due to the dominant BA.5 subvariant has shrunken to 68%, down from a peak of 87% in mid-August. The share attributed to potentially troublesome subvariants is up: BA.4.6 now likely makes up 12% of cases; BQ.1.1, 6%; BF.7, 5%; and BA.2.75.2, 1%.

While cases in the last fall-and-winter wave were far higher than during the first fall-and-winter surge, hospitalizations and deaths were lower. And Ferrer said she hopes that if more people get the updated Omicron-specific bivalent booster shot, any new seasonal wave will be less severe.

Many people who have been vaccinated and previously boosted are more than six months out from their last dose, making them more vulnerable to infection. Officials hope the new booster shot will reduce the likelihood of infection, as well as hospitalization and death.

For anyone who has been putting off getting their COVID-19 booster or flu shot, hoping to time it closer to the next wave, officials and experts say nows the time to do it, given that coronavirus transmission can start increasing in November, and for the flu, in December. It takes about two weeks after a COVID-19 booster or flu shot is given for a person to be considered fully protected.

In L.A. County, 81% of residents 12 and older have completed their primary COVID-19 vaccination series. Of residents in that age group who are eligible for a conventional booster shot, 59% have received one. But so far, just 7% of that eligible group has received the updated booster.

The updated booster designed to protect against not only the original coronavirus strain but also the currently dominant Omicron subvariants, including BA.5 has been available for those age 12 and up since early September.

People who never got an original booster after completing their primary COVID-19 vaccination series are also eligible for the updated shot.

If its been more than two months since you received your last booster or your primary vaccine series, you are eligible for the new bivalent booster which is the only vaccine that offers increased protection against Omicron, Ferrer said. Having a prior infection is not a guarantee that you will not be reinfected.

Federal officials on Wednesday cleared the way for updated COVID-19 booster shots to be made available for those ages 5 to 11. L.A. County expects shots for these children will be available as soon as Wednesday.

Early data from vaccine maker Pfizer suggest that the updated shot produces a substantial increase in the Omicron BA.4/BA.5 neutralizing antibody response above pre-booster levels. Data reported Thursday by the company suggest the booster is anticipated to provide better protection against the Omicron BA.4 and BA.5 variants than the original vaccine for younger and older adults.

Coronavirus case rates continue to fall in Los Angeles County, hitting a level not seen since mid-April. For the seven-day period that ended Thursday, the county was reporting about 950 new cases a day, or 66 new cases a week for every 100,000 residents. Thats down 20% from the prior week. A rate of 100 cases a week for every 100,000 residents is considered high; a rate between 50 and 99 is considered substantial.

However, falling case rates could be a reflection of fewer people getting tested for the coronavirus at facilities like hospitals or testing sites that send results to government agencies. In a possible sign of concern, coronavirus levels detected in L.A. County wastewater are no longer decreasing, Ferrer said, and likely what we are seeing is that viral transmission is no longer decreasing across the county.

New coronavirus-positive hospitalizations also are no longer decreasing in L.A. County. As of Thursday, there were 4.9 new weekly coronavirus-positive hospitalizations for every 100,000 residents, a rate that hasnt dropped substantially over the last three weeks.

Its not immediately clear why hospitalizations are no longer decreasing, even though the official case rate is still declining. It could be just noise in the data, Ferrer said. But another explanation could be that more people are getting infected than what is being captured in the official data, a reflection of so many people testing at home, where results arent reliably reported to health officials.

COVID-19 vaccinations have been credited with saving many lives. A report from the U.S. Department of Health and Human Services released recently suggested that high vaccination and booster rates among seniors likely resulted in roughly 350,000 fewer deaths and roughly 675,000 fewer hospitalizations among people who have Medicare.

Still, even though the U.S. is in a COVID-19 lull, there are 300 to 400 Americans dying daily from the illness, according to CDC data. Thats equivalent to 110,000 to 150,000 deaths a year far higher than the average number of flu deaths per year, which is about 35,000.

Officials are also urging people to get their flu shots, which are recommended for everyone 6 months and older.

It is reasonable to expect were going to have a significant flu season this year, in part because weve had very little flu in the last couple of years, said Dr. Ashish Jha, the White House COVID-19 response coordinator, said at a briefing recently.

The CDC has changed flu shot recommendations this year and is now urging specific turbocharged flu vaccines for seniors, including higher dose and adjuvanted shots, which help create a stronger immune response. Studies suggest that for seniors 65 and older, these vaccines are potentially more effective, the CDC said.

There are three flu vaccines in these categories: the Fluzone High-Dose Quadrivalent, Fluad Quadrivalent and Flublok Quadrivalent.

Older people are more likely to be hospitalized and die from the flu. The reason for this is, as we age, our immune systems unfortunately decline. Its the reason that we see more disease in [the] elderly, said Dr. Sharon Balter, director of L.A. Countys acute communicable disease control program.

The CDC said seniors should get the upgraded flu vaccines if possible, but if they arent available, they should get a standard-dose flu shot instead. Balter said she would hope that seniors would be offered the upgraded flu shot at a vaccine clinic, but said its always a good idea to ask about it.

Still, UC San Francisco infectious-disease expert Dr. Peter Chin-Hong said seniors dont need to look too hard for the higher-dose flu shots if they arent easily available. Its important to get any flu shot, instead of just searching to make sure you get the right one, Chin-Hong said recently at a campus town hall.

He said the challenging flu season in the Southern Hemisphere, where winter began in June and ended in September, is reason to suspect flu could be worse here this winter.

Why is flu going to be worse this year? Lower population immunity, more people traveling, restrictions dropped, and the writing on the wall from Australia, where it came earlier. It hit harder, much higher than 2019, Chin-Hong said.

For those wondering about whether to get the flu shot and the updated COVID-19 booster at the same time, health experts say its safe.

See more here:

Concerns about California winter COVID wave increase - Los Angeles Times

COVID-19 worse for heart inflammation than vaccine: study – CTV News

October 15, 2022

A new study has found that the risk of myocarditis, or inflammation of the heart muscle, is seven times higher with a COVID-19 infection than with the vaccine to protect against the disease.

Myocarditis patients may experience chest pain, breathlessness, or an irregular pulse. When inflammation is extreme, it can cause heart failure and even death.

One of COVID-19s complications includes myocarditis. The mRNA COVID-19 vaccine has previously been linked to heart problems, such as myocarditis in adolescent boys, even though immunizations have been demonstrated to lessen severe COVID-19 symptoms. Large studies, however, have not adequately assessed the relative risk of myocarditis related to infections and vaccinations.

The study, which was conducted by Pennsylvania State College of Medicine and published on Aug. 29 in the journal Frontiers in Cardiovascular Medicine, assessed and analyzed 22 global COVID-19 studies published between December 2019 and May 2022.

The studies included nearly 58 million patients with cardiac complications who belonged to one of two groups: the 2.5 million who contracted the virus compared to those who did not contract the virus, and the 55.5 million who received the COVID-19 vaccination in comparison to those who did not.

Our findings show that the risk of myocarditis from being infected by COVID-19 is far greater than from getting the vaccine, Navya Voleti, a co-author of the study said in a release.

Moving forward, it will be important to monitor the potential long-term effects in those who develop myocarditis.

The patients with COVID-19, both vaccinated and unvaccinated, were compared to those without the virus by the researchers. Regardless of immunization status, they discovered that COVID-19 patients had a 15-fold higher risk of myocarditis than people who did not catch the virus.

The rates of myocarditis in those who received the immunizations and those in unprotected persons were then independently compared by the researchers. Findings show that myocarditis rates among those who received the COVID-19 vaccine were only two times higher than those of uninfected individuals.

Based on these findings, the researchers concluded that the risk of myocarditis associated with COVID-19 was seven times greater than the risk associated with vaccinations.

The majority (61 per cent) of people who were diagnosed with myocarditis after receiving the vaccine or having COVID-19 were men, the researchers also found. In both the COVID-19 and vaccine groups, 1.07 percent of patients with myocarditis required hospitalization, and 0.01 percent died.

COVID-19 infection and the related vaccines both pose a risk for myocarditis. However, the relative risk of heart inflammation induced by COVID-19 infection is substantially greater than the risk posed by the vaccines, Paddy Ssentongo, a co-author of the study said in a release.

We hope our findings will help mitigate vaccine hesitancy and increase vaccine uptake.

See the original post:

COVID-19 worse for heart inflammation than vaccine: study - CTV News

Federal employees have more paid time off from OPM to get COVID-19 booster shots – Federal News Network

October 11, 2022

The Office of Personnel Management is making it a little easier for federal employees to get their booster doses of the COVID-19 vaccine.

Employees now have up to four hours of paid administrative leave, after OPM authorized the time off on Oct. 6. Feds can also use time off to take family members to get their doses of the vaccine. And any employees who are not yet vaccinated against COVID-19 can use the time off...

READ MORE

The Office of Personnel Management is making it a little easier for federal employees to get their booster doses of the COVID-19 vaccine.

Employees now have up to four hours of paid administrative leave, after OPM authorized the time off on Oct. 6. Feds can also use time off to take family members to get their doses of the vaccine. And any employees who are not yet vaccinated against COVID-19 can use the time off toward getting their first dose.

The authorized leave followed recent efforts from the Biden administration, encouraging Americans to get vaccinated this fall to try to prevent the spread of the illness and minimize disruptions from the pandemic. OPMs federal leave authorization aims to further that comprehensive effort, the agency wrote.

The updated vaccine provides the strongest available protection from the Omicron strain of the COVID virus, which did not exist when the original vaccine was developed, OPM wrote. Given the potential for infections to increase in the fall and winter, it is critical that Americans get a new, updated COVID-19 vaccine to stay protected.

The allotted four hours of paid administrative leave will cover the time it takes to get the shot, as well as travel time both to and from the vaccination site. Employees should also get approval from their agencies before taking the leave, OPM said.

Additionally, federal employees are eligible for up to two days off if they have an adverse reaction to the vaccine. Beyond the initial two days, employees can use their own sick leave to take additional time off until they recover.

The announcement from OPM was also in line with guidance from the Safer Federal Workforce Task Force, which said agencies must offer administrative leave to eligible employees, to receive COVID-19 vaccinations. In August, the task force also loosened its COVID-19 screening guidance for employees, contractors and other visitors to federal facilities.

Agencies can also extend some paid time off to federal employees who were directly impacted by the recent severe weather from Hurricanes Ian and Fiona.

Federal employees can use weather and safety leave in certain circumstances, including these two hurricanes, OPM said in an Oct. 7 announcement. Agencies can also authorize advance payments and travel reimbursements to employees who need to relocate due to a local emergency.

Typically, teleworking employees cannot use this type of leave, unless the conditions are directly affecting their telework location, such as a home office.

Telework continues to play a significant role during emergency situations by enabling a greater number of federal employees to work and supporting continuity of operations. Agencies should continue to promote and incorporate telework into their agency emergency planning, OPM wrote.

Currently, there are more than 3,400 federal workers deployed to Florida and the southeastern U.S. to help with response and recovery efforts. The number of federal teams supporting search and rescue operations has also doubled, adding six more groups to the response efforts, the White House wrote in an Oct. 1 fact sheet. The Federal Emergency Management Agency (FEMA) leads these operations.

OPM is also currently assessing the need for an Emergency Leave Transfer Program for employees impacted by Hurricane Ian. The agency authorizes ELTPs in emergency situations to let federal employees transfer their unused leave to employees who may need it as a result of a natural disaster.

There are some stipulations for the program, though. Agencies can only substitute advanced annual leave, sick leave or leave without pay thats used because of the given emergency.

This is very important, because if an ELTP is later established, employees will not be able to retroactively substitute donated annual leave for any accrued annual leave or sick leave they used because [of] the adverse effects of the disaster or emergency, OPM wrote.

There is also now some temporary flexibility from OPM for agencies that need to hire more staff to aid recovery efforts following Hurricanes Fiona and Ian.

The temporary federal hires can serve up to one year, and only work in roles that are directly related to hurricane recovery and relief efforts, OPM wrote in an Oct. 7 announcement. Agencies can extend the appointments in increments of one year at a time, for as long as the positions are needed.

Although public notice is not required when filling positions in the excepted service, OPM strongly encourages agencies to conduct appropriate recruiting and notice to meet agencies technical needs, the agency wrote.

The employees hired to the temporary positions for more than 90 days will generally be eligible for health, vision and dental benefits, but will not have access to the Thrift Savings Plan, life insurance or retirement benefits.

Read the rest here:

Federal employees have more paid time off from OPM to get COVID-19 booster shots - Federal News Network

IDPH Holds Vaccination Event in East St. Louis to Promote COVID-19 Booster and Flu Shots – IDPH

October 11, 2022

EAST ST. LOUIS Illinois Department of Public Health (IDPH) Director Dr. Sameer Vohra received a COVID-19 booster and a flu shot today in East St. Louis at the East Side Health District. Director Vohra appeared with State Senator Christopher Belt (D-Swansea) and State Representative LaToya Greenwood (D-East St. Louis) and stressed the importance of getting fully up-to-date with protection from COVID-19 and the flu ahead of the oncoming winter season.

The event was held as the CDC released data showing that 14 counties in Illinois are rated at Medium Community Level for COVID-19. IDPH is reporting 11,447 new confirmed and probable cases of COVID-19 in Illinois, including 62 deaths since September 30.

I feel very fortunate to have received both the COVID-19 bivalent booster and the flu shot today to protect myself and my family, said Director Vohra. With fall underway, its vitally important for everyone to protect themselves from both COVID-19 and the flu. We now have two powerful tools readily available to keep us safe, healthy, and protected during the fall and winter respiratory virus season. The new COVID-19 bivalent vaccines are designed to offer extra protection against the now-dominant Omicron strain of the virus.

Additionally, the seasonal influenza vaccines are designed to keep us protected from this seasons influenza strain. As we return to our pre-pandemic activities this winter, I encourage all of you to use these important tools to keep yourself and your loved ones healthy this upcoming holiday season.

More than 637,000 Illinoisans have received a dose of the new, bivalent COVID-19 vaccines since they were approved for use in early September, including 144,200 doses in the last week. Daily vaccination numbers are at the highest level seen since early February, during the major surge in illnesses caused by the Omicron variant.

I strongly encourage everyone to not hesitate and make arrangements now to get protected from both COVID-19 and the flu, Senator Belt said. Call the East Side Health District or your local healthcare provider and make sure that you and your family stay safe during the coming cold weather months and the family gatherings we all look forward to in the holiday season.

The new bivalent COVID-19 vaccines offer great protection against the virus, said Rep. Greenwood, who is the chairperson of the House Health Care Availability and Access Committee. I applaud the East Side Health District for making it easy for everyone in East St. Louis and the surrounding communities to get both a flu shot and the updated COVID booster.

Public health officials stress that the vaccines are especially important for those most vulnerable to severe illness, such as those individuals over 50, those with underlying medical conditions, and those who are immunocompromised.

IDPH reported that over the last week, an average of more than 20,000 doses of the new bivalent vaccines have been administered across the state each day. This is more than double the daily average for all vaccinations for most of the summer.

The CDC authorized two new bivalent booster vaccines on September 2 that include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an added mRNA component in common between the Omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by that variant.

The Moderna COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 18 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent, is authorized for use as a single booster dose in individuals 12 years of age and older.

The updated boosters are available at pharmacies, hospitals, and other healthcare providers. The best way to locate a vaccine provider near you is to visit http://www.vaccines.gov and search for bivalent booster availability.

Currently, IDPH is reporting a total of 3,773,667 cases, including 35,073 deaths, in 102 counties in Illinois since the beginning of the pandemic.

As of last night, 929 individuals in Illinois were reported to be in the hospital with COVID-19. Of those, 111 patients were in the ICU and 28 patients with COVID-19 were on ventilators. The preliminary seven-day statewide case rate is 90 COVID-19 cases per 100,000 Illinoisans.

In counties at the Medium Community Level, persons who are elderly or immunocompromised (at risk of severe outcomes) are advised to wear a mask in indoor public places. They should also get up to date on COVID-19 vaccines or get their bivalent booster, if eligible.

IDPH has been supporting pharmacies and healthcare providers in efforts to increase their inventories of the various FDA-authorized treatments. There are over 1,200 treatment locations in Illinois - including all the major retail pharmacies. More than 96.7% of the states population is within a 10-mile radius of one of these locations.

A total of 23,981,588 vaccines have been administered in Illinois. The seven-day rolling average of vaccines administered daily is 23,388 doses, including the bivalent booster and first doses. Since September 30, 163,713 doses were reported administered in Illinois. Of Illinois total population, more than 77% has received at least one COVID-19 vaccine dose, more than 70% of Illinois total population is fully vaccinated, and more than 55% of the vaccinated population has an initial booster according to data from the Centers for Disease Control and Prevention.

Data indicates that the risk of hospitalization and severe outcomes from COVID-19 is much higher for unvaccinated people than for those who are up to date on their vaccinations. All data are provisional and are subject to change. Additional information and COVID-19 data can be found at https://dph.illinois.gov/covid19.html.

Vaccination is the key to ending this pandemic. To find a COVID-19 vaccination location near you, go to http://www.vaccines.gov. The federal government has established a new website that provides an all-purpose toolkit with information on how to obtain masks, treatment, vaccines and testing resources for all areas of the country at: https://www.covid.gov/.

Read the rest here:

IDPH Holds Vaccination Event in East St. Louis to Promote COVID-19 Booster and Flu Shots - IDPH

COVID vaccines protect children: where are we now and how did we get here? – Contemporary Pediatrics

October 11, 2022

With 19,082 cases of COVID-19 per 100,000 children in the population, said Emmanuel B. Walter, MD, MPH, professor of Pediatrics, Duke Human Vaccine Institute Duke University School of Medicine, Durham North Carolina, and the explosion of variants in 2022, the rationale for the COVID-19 vaccine for children is simple, and something to continue to remind caregivers: it will prevent severe COVID-19 disease, hospitalizations, death, and complications such as MIS-C in children; and it will decrease the number of infections in children and thereby further decrease transmission of infection to others.

Walter went through a careful review of the current vaccines available and those being studies for children of various age groups, which includre AZD1222 (the AstraZeneca vaccine); Janssen COVID-19 vaccine; NVX-CoV2373 (Novavaxs COVID-19 vaccine); and BNT162b2 (Pfizer/BioNTech).

The future challenges, observed Walter, is in evaluating vaccines containing contemporary variants in children (Omicron BA.4/BA.5); development of a more broadly protective vaccine against coronaviruses in general; and increasing parental confidence in COVID-19 vaccines.

Finally, Walter urged clinicians, Consistently recommend and offer COVID-19 vaccines for children and adolescents in your practice, and monitor uptake of COVID-19 vaccine among vaccine eligible children and adolescents in your practice.

ReferenceWalter EB. Covid vaccines protect children: Where are we now and how did we get here? 2022 AAP National Conference & Exhibition. October 8, 2022. Anaheim, California.

See original here:

COVID vaccines protect children: where are we now and how did we get here? - Contemporary Pediatrics

Page 206«..1020..205206207208..220230..»